To test the hypothesis that inflammation in hepatitis C follows mechan
isms common to immune-activated pathways, the distributions of T and B
cells, adhesion molecules and transforming growth factor-beta (TGF-be
ta) were assessed in liver biopsies with chronic inflammation due to h
epatitis C (HCV, n=8) and other causes (non-HCV, n=10). Frozen section
s were immuno-stained using primary antibodies to CD2, CD20, CD4, CD8,
intercellular adhesion molecule (ICAM-1), vascular cell adhesion mole
cule (VCAM)-1, HLA-DR, lymphocyte function-associated antigen (LFA)-1,
and TGF-beta. Inflammatory cells positive for each immunophenotypic m
arker were counted, and positive staining for adhesion molecules, HLA-
DR and TGF-beta was graded in triads and lobules and compared in HCV a
nd non-HCV biopsies. In all biopsies, T cells were more frequent than
B cells, both in triads and lobules. CD20+, CD4+, CD8+ and LFA-1+ cell
s were increased in HCV compared to non-HCV biopsies. Portal lymphoid
aggregates were present in 6 of 8 HCV biopsies and 3 of 10 non-HCV bio
psies. Aggregates consisted of CD20+, CD4+, CD8+ and LFA-1+ cells, and
ICAM-1 and VCAM-1 were increased. Sinusoidal lining cells in HCV biop
sies and non-HCV biopsies with inflammation expressed HLA DR, ICAM-1,
and CD4. TGF-beta was increased in foci of necrosis. Inflammation in c
hronic HCV involves common immune-mediated cellular effector pathways
and the inflammation in the portal triads represents aggregation of bo
th T and B cells, mediated in part by upregulation of adhesion molecul
es on portal stromal cells; this is possibly in response to antigens d
raining from necroinflammatory foci in the lobules. TGF-beta is increa
sed in active necroinflammatory foci, but not in portal lymphoid aggre
gates.